TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change from Baseline Confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Absence of clinical symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year Event-Free Survival rate
Endpoint domain: Mortality/survival
Primary endpoint: The 10-meter walking test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Fugl Meyer Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Stroke Impact Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Acceptability of the mHealth application
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: intermediate survival
Endpoint domain: Mortality/survival
Primary endpoint: Rate and Duration of Symptomatic Relief
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 2-year Event Free Survival Rate
Endpoint domain: Mortality/survival
Primary endpoint: Intracranial Progression Free Survival (iPFS)
Endpoint domain: Mortality/survival
Primary endpoint: Percentage excess BMI loss at 2 years (%EBMIL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expiratory time constant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mechanical energy transferred to the lungs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Prenatal Comfort Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fetal Health Anxiety Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of erythematous papule, vesicle and/or eschar
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Microagglutination (MA) titer with a greater than or equal to 4 fold rise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Inverse remodeling of right heart chambers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Heart failure hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Receipt of Recommended NF1 Health Screenings
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Changes in kidney function decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Hemoglobin level (g/dl)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in antiviral activity in saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Clinical Assessment Scale in Autoimmune Encephalitis (CASE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and Severity of Adverse Effects (AEs) and Severe Adverse Effects (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number and type of adverse and protective CTA-derived plaque features
Endpoint domain: Adverse events/effects
Primary endpoint: Cognition, Consciousness and Awareness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immune response to SARS-CoV-2 vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in medication administration knowledge level
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Comparison of medication administration skill performances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comparison of Clinical Decision Making Skill Level
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in YGTSS-R total tic severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NeuroCom Sensory Organization Test (SOT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NeuroCom Limits of Stability test (LOS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NeuroCom Adaptation Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MiniBESTest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of ear-worn device information
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of Hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Degree of chimerism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confidence to Intervene on Sexual Harassment Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to Maximum Observed Concentration (Tmax) of Maribavir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Score on Visual Analog Scale for Abdominal Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to baseline opioid use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Area under the plasma concentration time curve (AUC) from time zero to 12h (AUC0-12)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC from time zero to the time of the last quantifiable concentration (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of HbA1c concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Appropriateness of medications used in surgeries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: CPV-measured variation in Assessment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: CPV-measured change in treatment Quality
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: CPV-measured differences in cost of care between control and intervention arms
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in Bimanual Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Murmurs detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Heart rhythm disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Complete cell-cycle arrest at C1D15
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood glucose Time-In-Range (TIR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Counter movement Jump Height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived recovery Visual Analog Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in transfusion number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in short-term patients' outcomes (perioperative complications)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in length of stay in hospital
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in Hb levels (g/dl) at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of all grade TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of ≥3 grade TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Plaque Index Simplified
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in naming ability of trained items at week 10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in naming ability of trained items at week 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Composite Driving Z Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in global end-expiratory lung impedance (EELI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of participants who received an influenza vaccine
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Gendolcat score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Categoric Pain Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short Edition of the Brief Pain Inventory
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: DN4 Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurological examination scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes cognitive impairment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes Activities of daily living
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes functionality
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes Upper limb dexterity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in carpal tunnel syndrome associated pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Empathy Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dementia care scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Virtual reality course experience scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Airway inflammation as assessed by exhaled nitric oxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Airway reactivity as assessed by airwave oscillometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Respiratory functioning as assessed by a mobile Spirometry device
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: The number of patients with PCR negative results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CNS penetration of telavancin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage change in pupil diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Salivary melatonin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in Hemorrhoid symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: gut microbiome diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PAC-SYM Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PAC-QOL Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Occurrence of Treatment-Related Adverse Events (TRAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in proliferative index (Ki67 expression)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with ≥50% reduction in cough attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Edinburgh Hand Preference Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nelson Hand Reaction Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ovarian reserve tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: percent of subjects without heavy drinking
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: World Health Organization index of well-being
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Constant -Murley Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to modification of antimicrobial treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Pain Scale (NPRS scale) when Lidocaine Infiltrated
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Scale (NPRS scale) when Epidural Needle Inserted
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient's Movement when Lidocaine Infiltrated
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient's Movement when Epidural Needle Inserted
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total recovery of HDM1002 radioactivity in urine and feces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma and whole blood AUC[0-t] of radioactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma and whole blood Cmax of radioactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Framingham score variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in SCARED-P Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: FAF retinal patterns comparison
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total OSDI SCORE
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: WMH shape
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of atelectasis after induction of general anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: percentage of atelectasis after being positioned in the trendelenburg position
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Migraine attack intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants reporting adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in alanine aminotransferase (ALT), aspartate aminotransferase (AST) and alkaline phosphatase parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Maximum toxicity grade increase from baseline in ALT, AST and alkaline phosphatase
Endpoint domain: Adverse events/effects
Primary endpoint: Symptomatic recurrent venous thromboembolism (VTE)
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of Eligible Participants Enrolled
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time to maximum blood copeptin concentration (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PHQ-9
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of patients with anastomotic leakage
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of time with oxygen saturation <80%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Recruitment capability of the study site - Incidence
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Recruitment capability of the study site - Prevalence
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Recruitment capability of the study site - Percent Eligible
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Recruitment capability of the study site - Percent Consent
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Recruitment capability of the study site - Percent Withdraw
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Dynamic Balance and Lower Extremity Functionality in Y-Balance Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BESS Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Movement Parameters Recorded by Noraxon Myomotion 5 IMU Sensors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brief Pain Inventory Pain Severity Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ebola-specific Antibody Titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 7-level COVID Ordinal Outcome Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first clinical and/or radiological disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-infectious peritoneal dialysis-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of activation of Event Related Desynchronization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Freedom from target vessel instability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Freedom from endograft instability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Efficacy of topical jessener solution in treatment of alopecia areata
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of days from admission until decannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Diagnostic epicardial coronary angiography images
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PED visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Serum Anti-Mullerian hormone Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Fecal metabolome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood biomarker expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: tumor biomarker expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Diagnostic yield of EBUS-TBNA samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dietary content of children's lunches
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: HBsAb positive rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HBsAg-specific T cell response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HBsAb protective efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Application visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptance
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of repeated school year
Endpoint domain: Life impact
Endpoint subdomain: Educational outcomes
Primary endpoint: Peripheral oxygen saturation (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart rate (per minute)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiratory rate (per minute)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systolic blood pressure (mm/Hg) and diastolic blood pressure (mm/Hg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of pressure ulcer
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Attitude of pressure ulcer
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Practice of pressure ulcer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to acalabrutinib discontinuation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Lung Cancer Screening Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Tobacco Treatment Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Glasgow Outcome Scale Extended at discharge
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Maternal and fetal hemodynamics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Indications for renal biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: PD-L1 Expression Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fatty acid turnover
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adipose tissue capillarization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Quality of Recovery 15 (QOR-15)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Post-discharge Surgical Recovery 13 (PSR-13)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: vascular changes in the posterior segment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Number of perforating arteries detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timing of completion of CHEQ items
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes